Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion type Assertion NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_head.
- NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion description "[In summary, our findings demonstrate that hMOF participates in human hepatocellular carcinoma by targeting SIRT6, and hMOF activators may serve as potential drug candidates for hepatocellular carcinoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_provenance.
- NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion evidence source_evidence_literature NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_provenance.
- NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion SIO_000772 25181338 NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_provenance.
- NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion wasDerivedFrom befree-2016 NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_provenance.
- NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_assertion wasGeneratedBy ECO_0000203 NP1216179.RAjsuOL-hyMsHmf3S5mLmA7UsXyFm6gcnmRESWwf0uItE130_provenance.